FIELD: pharmaceutical chemistry. SUBSTANCE: composition contains lipophilic sparingly soluble active substance in the form of liposomes, at least one phospholipid, distilled water, special adjuvants, and, additionally, at least one fatty acid with general formula H3C-(CH2)P-COOH, wherein n is 4 to 8, or salt of this acid at specified ratio of components. EFFECT: increased physico-chemical stability. 6 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM | 2017 |
|
RU2756755C2 |
| COLLOIDAL SOLUTION | 2008 |
|
RU2449776C2 |
| ERYTHROPOIETIN LIPOSOMAL DISPERSION | 1999 |
|
RU2218914C2 |
| PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES | 2011 |
|
RU2571283C2 |
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| BILAYER PREPARATIONS | 1995 |
|
RU2166332C2 |
| METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
| METHOD FOR PRODUCING LIPOSOMAL AGENT EXHIBITING WOUND HEALING ACTION | 2009 |
|
RU2417075C1 |
| METHOD FOR OBTAINING LIPOSOMES BEING OF IMMUNOCORRECTING AND HEPATOPROTECTOR ACTION | 2006 |
|
RU2308940C1 |
| MEDIUM OF CRYOPRESERVATION OF BULL SEMEN AND METHOD OF ITS PREPARATION | 2014 |
|
RU2577882C1 |
